Table 1.
Case No. | Author, year.reference | Age/Sex | Site | Size (cm) | Initial diagnosis | Gross finding | Mitosis | Immunohistochemical staining | Therapeutic operation | Ectopic pancreatic tissue | Assumed origin | Metastasis | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Sun and Wasserman, 2004.[4] | 86/F | antrum | 5.0 | PDAp | exophytic polypoid mass with ulcer | 0-3/ HPF | trypsin +, chymotrypsin +, A1AT f+, A1ACT f+, CD56 -, Syn -, Cg -, gastrin - | partial gastrectomy | absence | pure gastric form | absence | NM |
2 | Mizuno et al., 2007.[3] | 73/M | pylorus | 7.6 | GIST or lymphomac, IIBp | submucosal mass invading pancreatic head | NM | A1AT + | pancreatico-duodenectomy | absence | pure form | LN metastasis | liver metastasis at 7 months, alive after 11 months |
3 | Ambrosini-Spaltro et al., 2009.[1] | 52/M | antrum | 4.0 | PDAp | ulcerated mass | low mitotic index | A1AT +, Cg -, Syn -, gastrin - | subtotal gastrectomy | presence by pancreatic metaplasia | pancreatic metaplasia | absence | NM |
4 | Coyne, 2012.[2] | 77/F | fundus | 4.5 | PDAp | exophytic polypoid mass with ulcer | 3/10 HPF | trypsin +, A1AT +, CD56 f+, Syn w+, Cg -, serotonin -, insulin -, glucagon - | partial gastrectomy | absence | pure gastric form | absence | died from complications after 1 month |
5 | Yonenaga et al., case 2, 2016.[5] | 63/M | antrum | 6.5 | PDAp | Borrmann type-2 | 15/10 HPF | chymotrypsin +, A1ACT +, Cg f+, Syn f+, insulin -, glucagon -, gastrin -, somatostatin - | autopsy | absence | pure gastric form | liver | died from coexisting advanced PaDA after 5 months |
6 | Present case, 2016 | 54/M | cardia | 2.7 | GIST or lymphomac, IIBp | exophytic polypoid mass | 1/10 HPF | A1AT +, A1ACT +, CD56 w+, DOG1 w+, Syn -, Cg -, TTF-1 -, CD34 -, c-Kit - | laparoscopic wedge resection | absence | pure gastric form | absence | alive without disease after 33 months |
Abbreviations: M male, F female, PDA poorly differentiated adenocarcinoma, HPF high power field, NM not mentioned, GIST gastrointestinal stromal tumor, A1AT α1-antitrypsin, A1ACT α1-antichymotrypsin, Syn synaptophysin, Cg chromogranin, TTF-1 thyroid transcription factor 1, p pathologic diagnosis in endoscopic biopsy before the therapeutic operation; c clinical diagnosis before therapeutic operation; IIB inconclusive initial biopsy, LN lymph node, PaDA pancreatic ductal adenocarcinoma, + positive, f+ focally positive, w+ weakly positive, − negative